Latest Industry Trends & News

Recently Added

10/19/2018
orthopedic
3D-Printed Foot and Ankle Implants Are Successful in Complex Cases

A study published in “Foot & Ankle International” in August 2018 supports the use of customized, 3D-printed foot and ankle implants for complex lower extremity cases. Researchers from Duke Universi...

10/19/2018
orthopedic
NuVasive Partners With Biedermann

NuVasive, based in California, announced Oct. 9 that it has entered a partnership with German company Biedermann Technologies GmbH & Co. KG. This relationship will allow NuVasive to access intellec...

10/19/2018
breakingophthalmic
Allergan Recalls Ozurdex Implants over Possible Presence of Silicone Particle

Allergan is recalling several batches of its Ozurdex implant for retinal disease due to the possible presence of a silicone particle, and remaining batches that tested particle-free will be recalle...

10/19/2018
breakingophthalmic
FDA Approves EyePoint’s YUTIQ for Non-Infectious Uveitis

The US FDA has approved EyePoint Pharmaceuticals’ YUTIQ for chronic non-infectious uveitis affecting the posterior segment of the eye, the Watertown, Massachusetts, company announced Oct. 15. EyePo...

10/19/2018
breakingophthalmic
Hoya to Acquire Mid Labs, Fritz Ruck

Hoya Surgical Optics has entered an agreement to acquire Mid Labs and Fritz Ruck, the Japan-based company announced Oct. 18. Mid Labs is a California-based company focused on the research, innovati...

10/19/2018
breakingophthalmic
GenSight Reports Positive 72-Week Data in Phase III Trial of GS010 for LHON

GenSight Biologics’ Phase III clinical trial of GS010, its candidate for Leber hereditary optic neuropathy (LHON), produced positive results at 72 weeks, the Paris-based company announced Oct. 18. ...

10/19/2018
breakingophthalmic
FDA Goes After Drugmakers Using Citizen Petitions to Block Generic Competition

The US FDA announced Oct. 2 that it is revising its policies to make it harder for companies to use the agency’s citizen petition process to block or delay generic competitors from entering the mar...

10/19/2018
breakingophthalmic
Keen Eye, Iris Pharma Partner to Use AI in Ophthalmic Studies

Keen Eye has entered a strategic partnership agreement with Iris Pharma to provide Iris with artificial intelligence (AI) applications designed to make assays faster, more reliable, and more effici...

10/18/2018
ophthalmicpress release
Fundus Imaging Market to Generate $745 Million in 2018

The fundus imaging market will generate $745 million in total end-user revenues in 2018 and grow to $931 million by 2023 at a compound annual growth rate of 4.6 percent, according to Market Scope e...

10/16/2018
ophthalmicpress release
Retinal Pharmaceuticals Market to Grow at Rate of 10 Percent through 2023

The lucrative retinal pharmaceuticals market is attracting the attention of a host of new competitors. Thirteen drugs share sales in the $13.4 billion segment, but two drugs dominate the market and...

10/15/2018
ophthalmicpress release
Increasing Surgery Volume Will Fuel Single-Use Ophthalmic Surgical Device Market

Two factors will drive healthy growth in the single-use ophthalmic surgical product market over the next five years: an aging world population, which will lead to steady growth in ophthalmic surger...

10/12/2018
breakingophthalmic
Med X Launches 4Klear Surgical Microscope Camera

Med X Change announced Oct. 4 that it has launched its 4Klear surgical microscope camera, which combines a 4K camera and medical video recorder in a high quality system designed to simplify image m...

Past News Stories

10/12/2018
breakingophthalmic
EMA Accepts Aerie’s Filing for Rhokiinsa

The European Medicines Agency (EMA) has accepted Aerie Pharmaceuticals’ application for Rhokiinsa as a treatment for open-angle glaucoma or ocular hypertension, the company announced Oct. 9. Rhokii...

10/12/2018
breakingophthalmic
Sensimed Triggerfish Gains Approval in Japan

Sensimed AG announced Oct. 3 that its Sensimed Triggerfish sensor and monitoring system has gained regulatory approval from Japan’s Ministry of Health, Labour, and Welfare. The Swiss company said t...

10/12/2018
breakingophthalmic
Alcon Unveils Updates to WaveLight Refractive Suite

Alcon announced Oct. 2 that it has unveiled software and hardware enhancements to the WaveLight Refractive Suite, including updates to the laser that are intended to mitigate increases in intraocul...

10/12/2018
orthopedic
Corin Acquires Global Orthopaedic Technology

UK-based Corin announced its acquisition of Australian Global Orthopaedic Technology (GOT) on Oct. 5. Both companies are privately owned. GOT offers knee and hip implant products along with robotic...

10/12/2018
orthopedic
AAOS and The Joint Commission Work to Standardize Care for Hip and Knee Replacements

The American Academy of Orthopedic Surgeons (AAOS) announced Sept. 26 that it will be collaborating with The Joint Commission to standardize hip and knee replacement care. The Joint Commission esta...

10/12/2018
orthopedic
AxiaLIF Receives NICE Guidance for Approval

TranS1, a North Carolina company, announced on Sept.18 that the UK’s National Institute for Health and Care Excellence (NICE) recommended that TranS1’s presacral approach and AxiaLIF system be avai...

10/12/2018
orthopedic
Zavation Acquires PanMed

Privately owned, Mississippi-based Zavation announced its acquisition of another privately-owned company, Pan Medical US Corp. (PanMed), on Sept. 18. The price of the acquisition is not disclosed. ...

10/12/2018
orthopedic
MIACH Receives $22.5 M for Its Support ACL Implant

MIACH Orthopaedics, a privately owned company in Boston, announced Sept. 17 a successful round of Series A financing for trials and manufacturing of its Bridge-Enhanced ACL Repair (BEAR). Leading c...

10/12/2018
breakingophthalmic
Konan Medical USA Acquires objectiveFIELD Objective Perimeter

Konan Medical USA has acquired objectiveFIELD, an FDA-cleared perimeter, from the Australian National University, the company announced Oct. 11. Irvine, California-based Konan said the objectiveFIE...

10/12/2018
breakingophthalmic
Novaliq Raises $53 Million for Dry Eye Candidates

Novaliq has raised $53 million to support its lead assets—CyclASol and NOV03 for dry eye—and pipeline programs for glaucoma and retinal diseases, the German-based company announced Oct. 11. Novaliq...

10/12/2018
breakingophthalmic
Alexion’s Soliris Meets Primary Endpoint in Phase III Study for Neuromyelitis Optica Spectrum Disorder

Alexion’s Phase III study of Soliris for anti-aquaporin-4 (AQP4) auto antibody-positive neuromyelitis optica spectrum disorder (NMOSD) met its primary endpoint, the Boston company announced Sept 24...

10/12/2018
breakingophthalmic
Ophthotech Completes Recruitment for Phase IIb Trial of Zimura in GA

Ophthotech has completed patient recruitment for a Phase IIb clinical trial of Zimura as a monotherapy in patients with geographic atrophy (GA), the advanced form of dry age-related macular degener...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.